Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Bell CJM"'
Autor:
Lee M; JDRF/Wellcome Diabetes and Inflammation Laboratory, Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK., Bell CJM; JDRF/Wellcome Diabetes and Inflammation Laboratory, Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK., Rubio Garcia A; JDRF/Wellcome Diabetes and Inflammation Laboratory, Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK., Godfrey L; JDRF/Wellcome Diabetes and Inflammation Laboratory, Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK., Pekalski M; JDRF/Wellcome Diabetes and Inflammation Laboratory, Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK., Wicker LS; JDRF/Wellcome Diabetes and Inflammation Laboratory, Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK., Todd JA; JDRF/Wellcome Diabetes and Inflammation Laboratory, Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK., Ferreira RC; JDRF/Wellcome Diabetes and Inflammation Laboratory, Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK.
Publikováno v:
Discovery immunology [Discov Immunol] 2023 Aug 11; Vol. 2 (1), pp. kyad012. Date of Electronic Publication: 2023 Aug 11 (Print Publication: 2023).
Autor:
Peterson LB; Roche Innovation Center Basel, Roche Pharma Research & Early Development (pRED), Grenzacherstrasse 124, 4070, Basel, Switzerland; JDRF/Wellcome Diabetes and Inflammation Laboratory, Department of Medical Genetics, Cambridge Institute for Medical Research, NIHR Cambridge Biomedical Research Centre, University of Cambridge, Cambridge, CB2 OXY, UK., Bell CJM; JDRF/Wellcome Diabetes and Inflammation Laboratory, Department of Medical Genetics, Cambridge Institute for Medical Research, NIHR Cambridge Biomedical Research Centre, University of Cambridge, Cambridge, CB2 OXY, UK., Howlett SK; JDRF/Wellcome Diabetes and Inflammation Laboratory, Department of Medical Genetics, Cambridge Institute for Medical Research, NIHR Cambridge Biomedical Research Centre, University of Cambridge, Cambridge, CB2 OXY, UK., Pekalski ML; JDRF/Wellcome Diabetes and Inflammation Laboratory, Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK; JDRF/Wellcome Diabetes and Inflammation Laboratory, Department of Medical Genetics, Cambridge Institute for Medical Research, NIHR Cambridge Biomedical Research Centre, University of Cambridge, Cambridge, CB2 OXY, UK., Brady K; Roche Innovation Center Basel, Roche Pharma Research & Early Development (pRED), Grenzacherstrasse 124, 4070, Basel, Switzerland., Hinton H; Roche Innovation Center Zurich, Roche Pharma Research & Early Development (pRED), Wagistrasse 10, 8952, Schlieren, Switzerland., Sauter D; Roche Innovation Center Basel, Roche Pharma Research & Early Development (pRED), Grenzacherstrasse 124, 4070, Basel, Switzerland., Todd JA; JDRF/Wellcome Diabetes and Inflammation Laboratory, Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK; JDRF/Wellcome Diabetes and Inflammation Laboratory, Department of Medical Genetics, Cambridge Institute for Medical Research, NIHR Cambridge Biomedical Research Centre, University of Cambridge, Cambridge, CB2 OXY, UK., Umana P; Roche Innovation Center Zurich, Roche Pharma Research & Early Development (pRED), Wagistrasse 10, 8952, Schlieren, Switzerland., Ast O; Roche Innovation Center Zurich, Roche Pharma Research & Early Development (pRED), Wagistrasse 10, 8952, Schlieren, Switzerland., Waldhauer I; Roche Innovation Center Zurich, Roche Pharma Research & Early Development (pRED), Wagistrasse 10, 8952, Schlieren, Switzerland., Freimoser-Grundschober A; Roche Innovation Center Zurich, Roche Pharma Research & Early Development (pRED), Wagistrasse 10, 8952, Schlieren, Switzerland., Moessner E; Roche Innovation Center Zurich, Roche Pharma Research & Early Development (pRED), Wagistrasse 10, 8952, Schlieren, Switzerland., Klein C; Roche Innovation Center Zurich, Roche Pharma Research & Early Development (pRED), Wagistrasse 10, 8952, Schlieren, Switzerland., Hosse RJ; Roche Innovation Center Zurich, Roche Pharma Research & Early Development (pRED), Wagistrasse 10, 8952, Schlieren, Switzerland., Wicker LS; JDRF/Wellcome Diabetes and Inflammation Laboratory, Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK; JDRF/Wellcome Diabetes and Inflammation Laboratory, Department of Medical Genetics, Cambridge Institute for Medical Research, NIHR Cambridge Biomedical Research Centre, University of Cambridge, Cambridge, CB2 OXY, UK. Electronic address: lswicker@well.ox.ac.uk.
Publikováno v:
Journal of autoimmunity [J Autoimmun] 2018 Dec; Vol. 95, pp. 1-14. Date of Electronic Publication: 2018 Nov 13.